The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Low-Dose Naltrexone for Treating MS Symptoms
Verywell Health
05 January 2020
https://www.verywellhealth.com/naltrexone-for-ms-2440888
Dr. Armin Schwarzbach, Infections in Cancer and Autoimmune Disorders. Presented by Markus Berger.
Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.